Deutsche Bank Ag\ Atreca, Inc. Transaction History

Deutsche Bank Ag\

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.91 - $1.82 $26,774 - $53,548	-29,422 Reduced 67.9%	13,909 $15,000
Q2 2022 Aug 11, 2022	SELL	$1.56 - $3.25 $22,000 - $45,834	-14,103 Reduced 24.56%	43,331 $78,000
Q1 2022 May 13, 2022	BUY	$1.61 - $5.2 $67,058 - $216,585	41,651 Added 263.9%	57,434 $182,000
Q4 2021 Feb 11, 2022	SELL	$2.87 - $6.29 $86,031 - $188,549	-29,976 Reduced 65.51%	15,783 $48,000
Q3 2021 Nov 04, 2021	BUY	$4.91 - $9.07 $148,890 - $275,038	30,324 Added 196.46%	45,759 $285,000
Q2 2021 Aug 11, 2021	SELL	$7.82 - $13.8 $31,201 - $55,062	-3,990 Reduced 20.54%	15,435 $131,000
Q1 2021 May 13, 2021	SELL	$13.0 - $19.34 $22,880 - $34,038	-1,760 Reduced 8.31%	19,425 $297,000
Q4 2020 Feb 16, 2021	BUY	$13.03 - $17.09 $77,033 - $101,036	5,912 Added 38.71%	21,185 $342,000
Q3 2020 Nov 12, 2020	BUY	$12.67 - $23.19 $54,747 - $100,203	4,321 Added 39.45%	15,273 $213,000
Q2 2020 Aug 13, 2020	BUY	$12.52 - $23.45 $60,747 - $113,779	4,852 Added 79.54%	10,952 $233,000
Q1 2020 May 14, 2020	BUY	$11.4 - $27.28 $43,901 - $105,055	3,851 Added 171.23%	6,100 $101,000
Q4 2019 Feb 14, 2020	BUY	$9.68 - $18.67 $4,394 - $8,476	454 Added 25.29%	2,249 $34,000
Q3 2019 Nov 14, 2019	BUY	$10.42 - $22.04 $18,703 - $39,561	1,795 New	1,795 $20,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.